Some industry-FDA interactions may be smoother now that the agency has recalled some policy staff that had been subject to reduction-in-force notices. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
